dimanche 15 novembre 2026
RechercherExplore
fr.via.news
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· January 15, 2026

E-Learning Research Report 2026-2031: Extensive Product Portfolios, Robust LMS Platforms, and Institutional Partnerships Consolidate Market Leadership

View original at globenewswire.com
E-Learning Research Report 2026-2031: Extensive Product Portfolios, Robust LMS Platforms, and Institutional Partnerships Consolidate Market Leadership Dublin, Jan…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • EU GDP was 1.0% higher in real terms in 2024 than in 2023

    80% confidence

  • China is growing at a CAGR of 16.15% during the forecast period

    80% confidence

  • APAC is the second largest share and fastest growing market of the global e-learning market

    80% confidence

  • The global e-learning market is moderately concentrated and highly competitive

    80% confidence

  • The E-Learning Market was valued at USD 325 Billion in 2025, and is projected to reach USD 665.06 Billion by 2031, rising at a CAGR of 12.68%

    80% confidence

  • The market faces challenges from proliferation of low-cost, open-access, and unregulated content providers, particularly in developing regions

    80% confidence

  • Kahoot! has 8 million teachers and 1.6 billion users globally in 2024

    80% confidence

  • North America is the largest e-learning market in 2025, with the US accounting for over 80% of the region

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
E-Learning Research Report 2026-2031: Extensive Product Portfolios, Robust LMS Platforms, and Institutional Partnerships Consolidate Market Leadership: Source | Via News | fr.via.news